Theodore H. Stanley, Director at Insys Therapeutics, Inc. (INSY), bought 500 shares at $73.30 ($36K) on 2014-03-12, disclosed to the SEC on 2014-03-13.
Open-market purchase of $36k INSY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.30 | 100 | $7K | 20.2% |
| 2 | $73.50 | 100 | $7K | 20.3% |
| 3 | $70.75 | 100 | $7K | 19.5% |
| 4 | $72.20 | 100 | $7K | 19.9% |
| 5 | $72.90 | 100 | $7K | 20.1% |
| Total | $72.53 avg | 500 |
| $36K |
| 100% |
| Filing → |
| INSY | SELL | 2016-03-04 | $362K | — | Filing → |
| INSY | SELL | 2015-09-14 | $148K | — | Filing → |
| INSY | SELL | 2015-03-10 | $198K | — | Filing → |